(Q43252637)

17 November 2017

title

Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate (English)

1 reference

metastatic renal cell carcinoma

17 November 2017

1 reference

1 reference

1 reference

3

1 reference

17 November 2017

4

1 reference

17 November 2017

A Soleimani

1

1 reference

17 November 2017

A Berntsen

series ordinal

2

1 reference

17 November 2017

publication date

1 November 2009

1 reference

Scandinavian Journal of Immunology

17 November 2017

published in

1 reference

17 November 2017

volume

70

1 reference

17 November 2017

issue

5

1 reference

17 November 2017

page(s)

481-489

1 reference

Infiltration of activated dendritic cells and T cells in renal cell carcinoma following combined cytokine immunotherapy

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2009.02322.X

A synthetic peptide homologous to functional domain of human IL-10 down-regulates expression of MHC class I and Transporter associated with Antigen Processing 1/2 in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2009.02322.X

IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2009.02322.X

Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2009.02322.X

10.1111/J.1365-3083.2009.02322.X

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference